IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 171 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $398,557 | +195.5% | 87,595 | +357.2% | 0.00% | – |
| Q2 2023 | $134,879 | -41.6% | 19,159 | +115.6% | 0.00% | – |
| Q2 2021 | $231,000 | -28.0% | 8,888 | +28.4% | 0.00% | -100.0% |
| Q4 2020 | $321,000 | +24.4% | 6,924 | -11.5% | 0.00% | 0.0% |
| Q3 2020 | $258,000 | +16.7% | 7,824 | -3.0% | 0.00% | 0.0% |
| Q2 2020 | $221,000 | -13.3% | 8,068 | -5.2% | 0.00% | 0.0% |
| Q1 2020 | $255,000 | -0.8% | 8,508 | -8.3% | 0.00% | 0.0% |
| Q4 2019 | $257,000 | +5.3% | 9,283 | -30.6% | 0.00% | 0.0% |
| Q3 2019 | $244,000 | -36.0% | 13,383 | -14.0% | 0.00% | 0.0% |
| Q2 2019 | $381,000 | – | 15,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |